Scarica l'app Stockscreener
5.83
15.13%
0.766
Dopo l'orario di chiusura:
5.85
0.02
+0.34%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$5.064
Aprire:
$5.12
Volume 24 ore:
287.18K
Relative Volume:
2.97
Capitalizzazione di mercato:
$37.90M
Reddito:
$9.00M
Utile/perdita netta:
$-7.21M
Rapporto P/E:
-10.60
EPS:
-0.55
Flusso di cassa netto:
$-7.59M
1 W Prestazione:
-28.57%
1M Prestazione:
-56.38%
6M Prestazione:
-94.72%
1 anno Prestazione:
-98.70%
Intervallo 1D:
$5.12
$6.93
Intervallo di 1 settimana:
$4.365
$8.265
Portata 52W:
$4.365
$2,655.00
Applied Dna Sciences Inc Stock (APDN) Company Profile
Nome
Applied Dna Sciences Inc
Settore
Industria
Telefono
631-240-8800
Indirizzo
50 HEALTH SCIENCES DRIVE, STONY BROOK, NY
Confronta APDN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
APDN
Applied Dna Sciences Inc
|
5.83 | 3.42M | 9.00M | -7.21M | -7.59M | -0.55 |
|
TMO
Thermo Fisher Scientific Inc
|
396.47 | 152.34B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
189.23 | 135.39B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
514.80 | 41.54B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
111.05 | 31.59B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
139.10 | 24.31B | 15.50B | 1.33B | 2.16B | 7.34 |
Applied Dna Sciences Inc Stock (APDN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2021-02-12 | Iniziato | ROTH Capital | Buy |
| 2021-01-14 | Reiterato | H.C. Wainwright | Buy |
| 2020-12-18 | Reiterato | H.C. Wainwright | Buy |
| 2020-07-20 | Reiterato | H.C. Wainwright | Buy |
| 2020-07-02 | Iniziato | H.C. Wainwright | Buy |
| 2016-11-14 | Reiterato | Maxim Group | Buy |
| 2016-05-13 | Reiterato | Maxim Group | Buy |
| 2015-10-08 | Reiterato | Maxim Group | Buy |
| 2015-05-26 | Iniziato | The Benchmark Company | Speculative Buy |
| 2015-02-10 | Reiterato | Maxim Group | Buy |
| 2015-01-13 | Iniziato | Maxim Group | Buy |
Mostra tutto
Applied Dna Sciences Inc Borsa (APDN) Ultime notizie
Applied DNA Reschedules Intra-Quarter Webcast and Investor Update Call to June 17 - Chronicle-Tribune
Applied DNA Announces 1-For-15 Reverse Stock Split Effective June 2, 2025 - Knoxville News Sentinel
Applied DNA Sciences, Inc. (NASDAQ:APDN) Short Interest Update - Defense World
APDN stock plunges to 52-week low of $0.32 amid market challenges By Investing.com - Investing.com South Africa
APDN Trading Halted as Market Awaits Significant Announcement | APDN Stock News - GuruFocus
APDN stock plunges to 52-week low of $0.32 amid market challenges - Investing.com Nigeria
Applied DNA Reschedules Intra-Quarter Webcast and Investor Update Call to June 17 | APDN Stock News - GuruFocus
Applied DNA Sets Reverse Stock Split for June 2, Moves Key Investor Call to June 17 - Stock Titan
Applied DNA Sciences Approves Reverse Stock Split - TipRanks
Applied DNA Sciences (APDN) to Implement 1-for-15 Reverse Stock Split | APDN Stock News - GuruFocus
Applied DNA Announces 1-For-15 Reverse Stock Split Effective June 2, 2025 | APDN Stock News - GuruFocus
Applied DNA Sciences Announces Major 1:15 Reverse SplitShares Drop from 7.8M to 519K in Nasdaq Bid - Stock Titan
Applied DNA Sciences (NASDAQ:APDN) Stock Rating Lowered by Wall Street Zen - Defense World
Applied DNA Sciences Holds Annual Stockholder Meeting - TipRanks
APDN stock plunges to 52-week low of $0.62 amid market challenges By Investing.com - Investing.com South Africa
APDN stock plunges to 52-week low of $0.62 amid market challenges - Investing.com Australia
Applied DNA Sciences Second Quarter 2025 Earnings: Misses Expectations - Yahoo Finance
Applied DNA Sciences Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Applied DNA Sciences: Fiscal Q2 Earnings Snapshot - CT Insider
Applied DNA Reports Second Quarter Fiscal 2025 Financial Results | APDN Stock News - GuruFocus
Applied DNA Reports Second Quarter Fiscal 2025 Financial Results - Jonesboro Sun
Applied DNA to Announce Second Quarter Fiscal 2025 Financial Res - GuruFocus
Applied DNA to Announce Second Quarter Fiscal 2025 Financial Results on May 15, Schedules Intra-Quarter Investor Update Call for June 3 - ACCESS Newswire
Applied DNA Announces Double Update: Q2 Earnings Plus Special Strategic Priorities Discussion - Stock Titan
Applied Dna Sciences Inc (APDN)’s Day in Review: Closing at 0.85, Down by -2.41 - DWinneX
Applied DNA Sciences Inc expected to post a loss of $3.00 a shareEarnings Preview - TradingView
Geode Capital Management LLC Grows Holdings in Applied DNA Sciences, Inc. (NASDAQ:APDN) - Defense World
Applied Dna Sciences Inc (APDN) is an excellent investment, but the stock is overvalued/undervalued right now - uspostnews.com
Applied DNA Sciences (APDN) to Release Quarterly Earnings on Friday - Defense World
Investing in Applied Dna Sciences Inc (APDN) Is Getting More Attractive - knoxdaily.com
Ratios Revealed: Decoding Applied Dna Sciences Inc (APDN)’s Financial Health - DWinneX
Financial Analysis: Applied Dna Sciences Inc (APDN)’s Ratios Unveil Key Insights - DWinneX
Press Release Distribution & PR Platform - ACCESS Newswire
Applied DNA Announces Pricing of $6.5 Million Registered Direct Offering and Concurrent Private Placement - ACCESS Newswire
Analysts Say Applied Dna Sciences Inc (NASDAQ:APDN) Can Really Get To 1.5 In 12 Months - Marketing Sentinel
Applied Dna Sciences Inc [APDN] Investment Appeal on the Rise - knoxdaily.com
Market Highlights: Applied Dna Sciences Inc (APDN) Ends on a High Note at 0.90 - DWinneX
Applied Dna Sciences Inc (APDN) Stock: A 52-Week Tale of Drops and Gains - investchronicle.com
Applied Dna Sciences Inc Azioni (APDN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.61%
1.59%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):